| 标题： | 乌司他丁临床应用急诊专家共识 |
| title： | Emergency experts consensus on clinical application of Ulinastatin |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 综合 |
| field： | Comprehensive guideline |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 临床医生 |
| Guide users： | Clinician |
| 证据分级方法： | 初步考虑采用Grade分级 |
| Evidence grading method： | Grade classification is preliminarily considered |
| 制定单位： | 西安交通大学第二附属医院 |
| Formulating unit： | the Second Affiliated Hospital of Xi'an Jiaotong University |
| 注册时间： | 2022-07-13 |
| Registration time： | |
| 注册编号： | IPGRP-2022CN400 |
| Registration number： | |
| 指南制订的目的： | 乌司他丁是丝氨酸蛋白酶抑制剂，且具有抗炎作用，在休克、脓毒症、急性呼吸窘迫综合征及烧伤等疾病中的应用价值已被临床认可，且已被多部专家共识或指南推荐。但由于目前尚缺乏围绕乌司他丁的统一的临床应用指南或规范，因此不便于临床医生在实际工作中使用。为规范乌司他丁在急危重症领域的合理应用，因此，拟制定《乌司他丁临床应用急诊专家共识》。 |
| Purpose of the guideline： | Ulinastatin is a serine protease inhibitor with anti-inflammatory effect. Its application value in shock, sepsis, acute respiratory distress syndrome, burns and other diseases has been clinically recognized, and has been recommended by many experts consensus or guidelines. However, due to the lack of unified clinical application guidelines or specifications around Ulinastatin, it is not convenient for clinicians to use it in practical work. In order to regulate the rational application of ulinastatin in the field of acute, critical and severe diseases, it is proposed to formulate the "Emergency experts consensus on clinical application of Ulinastatin". |
